Tarsus Welcomes Dr. Elizabeth Yeu as New Chief Medical Officer

Tarsus Pharmaceuticals has announced that Elizabeth Yeu, M.D., a highly respected ophthalmologist and long-time member of the Tarsus team, has stepped into the role of Chief Medical Officer, effective November 4, 2024. Dr. Yeu brings over 20 years of clinical expertise and has been integral to Tarsus as Chief Medical Advisor since 2020 and a Board member since 2021.

As Chief Medical Officer, Dr. Yeu will lead Tarsus’ new Medical Organization, overseeing teams dedicated to medical affairs, pharmacovigilance, and evidence generation, while also prioritising patient safety and medical education. In her new role, she will be part of the Executive Team, reporting directly to CEO and Chairman Bobby Azamian, M.D., Ph.D. With this appointment, Dr. Yeu has transitioned from her position on the Board to focus on her expanded responsibilities. This step underscores Tarsus’ commitment to advancing patient care, especially in eye health, through innovative science and technology.

Dr. Azamian, said in a statement, “Liz has been an invaluable partner and advisor to Tarsus, and we are thrilled to apply her medical expertise and leadership directly to enhancing the impact of our medical organisation as we continue to propel the XDEMVY launch. Her unique clinical perspective will be critical to our continued success and leadership in eye care and beyond, as we advance other meaningful pipeline programs addressing areas of significant unmet need.”

Dr. Elizabeth Yeu, expressed his excitement by saying, “I’m fortunate to have been a part of the Tarsus journey since the early days and am delighted for the opportunity to work even more closely with such a talented and passionate team. I look forward to contributing full time to the Company’s efforts to deliver novel therapies, such as XDEMVY, to more patients and ensuring my fellow clinicians have the evidence and information they need to provide optimal care to their patients.”

Dr. Elizabeth Yeu will continue her clinical practice as a partner and ophthalmologist at Virginia Eye Consultants, where she has built an impressive reputation in the field. Known for her expertise, Dr. Yeu has published hundreds of articles and frequently speaks on crucial areas of eye care, such as refractive cataract surgery, anterior segment reconstruction, and managing external ocular diseases.

Beyond her clinical work, Dr. Yeu is deeply involved in national ophthalmic leadership. She serves on multiple medical boards and committees, including as an examiner for the American Board of Ophthalmology. Additionally, she chairs the Refractive Surgery Section for the American Academy of Ophthalmology’s Annual Meeting Program Committee and is the immediate Past President of the American Society of Cataract and Refractive Surgery (ASCRS).

Dr. Elizabeth Yeu is also an active Board member for STAAR Surgical, the Virginia Eye Foundation, and CVP Physicians, Mid Atlantic, where she contributes her expertise and passion for advancing eye care. Her journey began with a seven-year honours program that led to her medical degree from the University of Florida College of Medicine. 

She then completed her ophthalmology residency at Rush University Medical Center, where she served as Chief Resident, and went on to a fellowship at Baylor College of Medicine’s Cullen Eye Institute, where she later became an Assistant Professor. Today, Dr. Yeu continues to share her knowledge and mentor future ophthalmologists as an Assistant Professor of Ophthalmology at Eastern Virginia Medical School.